SLC39A1 and Alzheimer disease: Similar changes in expression levels of ZIP1 have been seen in a Drosophila model of AD leading these authors to suggest that manipulating Zn2+ transporters in AD brains could be a novel therapeutic strategy (Lang et al., 2012).